Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
---|
01/10/2001 | EP1066271A1 Thiocarboxamide derivatives and their use as inhibitors of alpha-4 integrins |
01/10/2001 | EP1066261A1 Pyridine derivative and pharmaceutical containing the same |
01/10/2001 | EP1066260A1 Pyridine/picoline production process |
01/10/2001 | EP1066255A1 Method for producing lactams using oligophosphate catalysts |
01/10/2001 | EP1066251A1 Method for the production of 1,3-disubstituted 2-nitroguanidines |
01/10/2001 | EP1066247A1 Inhibitors of serine proteases, particularly hepatitis c virus ns3 protease |
01/10/2001 | EP1066246A1 Novel cationic couplers and their use for oxidation dyeing |
01/10/2001 | EP1066034A1 Oxy-vanadium (iv) complexes having spermicidal activity |
01/10/2001 | EP1066022A1 Compositions for oxidation dyeing keratin fibres comprising a cationic coupler, novel cationic couplers, their use for oxidation dyeing and dyeing methods |
01/10/2001 | EP1056722A4 Bisulfate salt of hiv protease inhibitor |
01/10/2001 | EP0854899B1 Fluorine-substituted alkenyl liquid crystalline compounds |
01/10/2001 | CN1279682A bicyclic kinase inhibitors |
01/10/2001 | CN1279672A Pyridazine derivatives and drugs containing the same as the active ingredient |
01/09/2001 | US6172261 Biosynthesis using chain extension |
01/09/2001 | US6172228 Process for producing piperazinesulfonamide derivatives and salts thereof |
01/09/2001 | US6172113 Bicyclic amino derivatives and PGD2 antagonist containing the same |
01/09/2001 | US6172108 Hydrazide compounds |
01/09/2001 | US6172103 Treating bone disorders, osteoporosis, and arthritis |
01/09/2001 | US6172091 Metabolic calcium imbalance and osteoporosis |
01/09/2001 | US6172082 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
01/09/2001 | US6172068 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses |
01/09/2001 | US6172064 Formamides as therapeutic agents |
01/09/2001 | US6172060 Therapy for sexual disorders |
01/09/2001 | US6172057 Antiinflammatory agents; antiarthritic agents; antitumor agents |
01/09/2001 | US6171522 Heterocyclic aromatic anion salts, and their uses as ionic conducting materials |
01/09/2001 | CA2203384C Conjugated n-fluoropyridinium salt-containing polymer and use of the same |
01/09/2001 | CA2111854C Orally active antiviral compounds |
01/09/2001 | CA2031766C 2-substituted phenyl-2-oxazoline or thiazoline derivatives, process for producing the same and insecticides and acaricides containing the same |
01/04/2001 | WO2001000623A1 Method of producing nitroguanidine- and nitroenamine derivatives |
01/04/2001 | WO2001000595A1 Method for producing 2-heterocyclyl methyl benzoic acid derivatives |
01/04/2001 | WO2001000581A1 Ligands based on chiral 2-amino-2'-hydroxy-1,1'-binaphthyl and related frameworks for asymmetric catalysis |
01/04/2001 | WO2001000580A1 2-(optionally substituted benzoylamino)-6-(optionally substituted phenoxy)pyridine derivatives, process for the preparation thereof and herbicides |
01/04/2001 | WO2001000579A1 COMPOUNDS FOR THE MODULATION OF PPARη ACTIVITY |
01/04/2001 | WO2001000578A1 1-(aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof |
01/04/2001 | WO2001000575A1 Heterocyclic dicarboxylic acid diamide derivatives, agricultural/horticultural insecticides and method of using the same |
01/04/2001 | WO2001000548A1 Compound having tetrahydronaphthalene skeleton and liquid crystal composition containing the same |
01/04/2001 | WO2001000229A1 Combination of tumors necrocis factor (tnf) antagonists and cox-2 inhibitors for the treatment of inflammation |
01/04/2001 | WO2001000208A1 Substituted pyridones having cytokine inhibitory activity |
01/04/2001 | WO2001000206A1 Vla-4 inhibitor compounds |
01/04/2001 | WO2001000197A2 Methods of treating fungal infections with inhibitors of nad synthetase enzyme |
01/04/2001 | WO2001000021A1 Pyrithione biocides enhanced by silver, copper, or zinc ions |
01/04/2001 | WO2000038715A3 Use of an integrin antagonist and radiation in the treatment of neoplasia |
01/04/2001 | WO2000030589A3 Synthesis of intermediates useful in preparing tricyclic compounds |
01/04/2001 | WO1998005610A3 Process for preparing fluorine-containing compounds |
01/04/2001 | DE19930075A1 Neue Amino- und Amidosulfonamide als antivirale Mittel New amino and Amidosulfonamide as antiviral agents |
01/04/2001 | CA2376892A1 Methods of treating fungal infections with inhibitors of nad synthetase enzyme |
01/04/2001 | CA2370500A1 1-(aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof |
01/04/2001 | CA2369308A1 Vla-4 inhibitor compounds |
01/04/2001 | CA2369145A1 Combination of tumors necrocis factor (tnf) antagonists and cox-2 inhibitors for the treatment of inflammation |
01/03/2001 | EP1065203A2 Heterocyclic compounds as retinoic acid receptor antagonists |
01/03/2001 | EP1064274A1 Benzenesulfonamide derivatives and their use as medicaments |
01/03/2001 | EP1064265A1 Synthesis of 3-amino-2-chloro-4-methylpyridine from malononitrile and acetone |
01/03/2001 | EP1064264A1 Cytotoxic metal chelators and methods for making and using same |
01/03/2001 | EP1064263A2 Nonnucleoside inhibitors of reverse transcriptase for the treatment of hiv-infection |
01/03/2001 | EP1063984A1 Inflammatory cell inhibitors |
01/03/2001 | EP0832057B1 Diaromatic propynyl or dienyl compounds |
01/03/2001 | CN1278807A Herbicidal N-alkenyl Heteroaryloxyacetamides |
01/03/2001 | CN1278795A Process for making diaryl pyridines useful as cox-2 inhibitors |
01/03/2001 | CN1278793A Sulfonyl derivatives |
01/03/2001 | CN1278791A Process for the preparation of azacyclkylalkanoyl pseudotetrapeptides |
01/03/2001 | CN1278789A 9,10-Dihydro-9,10-ethanoanthracene derivatives as phospholipase inhibitors |
01/03/2001 | CN1278785A Vanadium complexes of monohydroxamates and pharmaceutical compositions comprising them |
01/03/2001 | CN1060161C N-substituted phenylcarbamic acid derivatives, process for production thereof, agricultural and horticultural fungicides, intermediats of derlvatives and process for production thereof |
01/02/2001 | US6169184 Process for the production of substituted phenylpyridines |
01/02/2001 | US6169183 Process for preparing pyridinecarboxylic esters |
01/02/2001 | US6169101 Fungicides |
01/02/2001 | US6169075 Antitumor agent inhibiting the proliferation of a range of rapidly dividing tumour cells like melanoma and/or lymphoma cells |
01/02/2001 | US6168838 Fluorinated phenantrene derivatives for liquid crystal mixtures |
01/02/2001 | CA1341163C Oxime ether derivatives, their preparation and fungicides containing these derivatives |
01/02/2001 | CA1341162C Sbustituted aminomethyltetralins and their heterocyclic analogues |
12/28/2000 | WO2000078756A1 Thiophene-ethyl thiourea compounds and their use in the treatment of hiv |
12/28/2000 | WO2000078755A1 Thiophene-ethyl thiourea compounds and use in the treatment of hiv |
12/28/2000 | WO2000078721A1 Phenetyl-thiourea compounds for treating hiv infections |
12/28/2000 | WO2000078712A1 Substituted arylmalonic acid dinitriles as intermediates for the prepartion of herbicides |
12/28/2000 | WO2000078708A1 Substituted benzamide inhibitors of rhinovirus 3c protease |
12/28/2000 | WO2000078315A1 Cyclohexenyl-ethyl-thiourea compounds and use |
12/28/2000 | WO2000078303A1 Non-malignant disease treatment with ras antagonists |
12/28/2000 | DE19929348A1 Pure 2-heterocyclylmethyl-benzoic acid derivative preparation in high yield, for use as pharmaceutical or agrochemical intermediate, from phthalide compound and nitrogen-containing heterocycle |
12/28/2000 | CA2375356A1 Substituted benzamide inhibitors of rhinovirus 3c protease |
12/28/2000 | CA2375342A1 Phenetyl-thiourea compounds for treating hiv infections |
12/28/2000 | CA2375261A1 Thiophene-ethyl thiourea compounds and use in the treatment of hiv |
12/28/2000 | CA2368827A1 New intermediates |
12/27/2000 | EP1062255A1 Homopolymer of ethylene |
12/27/2000 | EP1062251A1 Polymerisation catalyst |
12/27/2000 | EP1062250A1 Polymerisation catalysts |
12/27/2000 | EP1062249A1 Polymerisation catalysts |
12/27/2000 | EP1062218A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases) |
12/27/2000 | EP1062199A1 Modulators of protein tyrosine phosphatases (ptpases) |
12/27/2000 | EP1061921A1 Vitronectin receptor antagonists |
12/27/2000 | EP1061908A1 Combination therapy and composition for acute coronary ischemic syndrome and related conditions |
12/27/2000 | EP1012141A4 Supernucleophilic 4-substituted-pyridine catalysts, and processes useful for preparing same |
12/27/2000 | EP0821671B1 Arylsulfonyl hydroxamic acid derivatives as mmp and tnf inhibitors |
12/27/2000 | EP0808304B1 2,3-substituted pyridines for the treatment of inflammation |
12/27/2000 | CN1278272A Polymerization catalysts |
12/27/2000 | CN1278255A Cyclopentene derivatives useful as antagonists of the motilin receptor |
12/27/2000 | CN1278250A Vitronectin receptor antagonists |
12/27/2000 | CN1278247A Alpha-hydroxy, amino and -fluoro derivatives of beta-sulphenyl hydroxamic acids matrix metalloproteinases inhibitors |
12/27/2000 | CN1278245A Malonic acid based matric metalloproteinase inhibitors |
12/27/2000 | CN1278244A Dipeptide nitriles |
12/27/2000 | CN1278167A Amide derivatives |